Sleeswijk Visser Tjerk S O, van der Vlist Arco C, van Oosterom Robert F, van Veldhoven Peter, Verhaar Jan A N, de Vos Robert-Jan
Department of Orthopedic Surgery and Sports Medicine, Erasmus MC University Medical Centre, Rotterdam, Netherlands.
Department of Orthopedic Surgery, Leiden University Medical Centre, Leiden, Netherlands.
BMJ Open Sport Exerc Med. 2021 Mar 26;7(1):e001023. doi: 10.1136/bmjsem-2020-001023. eCollection 2021.
To evaluate the impact of Achilles tendinopathy (AT) on quality of life (QoL), work performance, healthcare utilisation and costs in adults with conservatively treated chronic midportion AT.
This cross-sectional survey-based study included 80 patients and took place in a sports medicine department of a large regional hospital in the Netherlands. Data were collected before any intervention was given. Primary outcome was the EuroQol questionnaire (EQ-5D). The EQ-5D expresses the percentage of moderate/major problems on the domains self-care, anxiety/depression, mobility, usual activities and pain/discomfort. Secondary outcomes were the number of previous healthcare visits, work performance during the period of symptoms and estimated annual direct medical and indirect costs per patient as a result of AT.
All 80 patients completed the questionnaires. The EQ-5D scores were low for the domains self-care (1%) and anxiety/depression (20%), and high for the domains mobility (66%), usual activities (50%) and pain/discomfort (89%). Patients with AT mainly reported an impact on work productivity (38%). Work absenteeism due to AT was present in 9%. The total median (IQR) number of annual healthcare visits was 9 (3-11). The total mean (SD) estimated annual costs were €840 (1420) per patient with AT (mean (SD) US$991 (1675)).
This study shows the large impact of AT on QoL and work productivity. This study also provides new information about the socioeconomic impact of AT, which emphasises that this common and longstanding disease causes substantial costs. These findings stress the need for optimised treatment and improved preventive interventions for AT.
NCT02996409.
评估跟腱病（AT）对保守治疗的慢性中段跟腱病成年患者生活质量（QoL）、工作表现、医疗保健利用情况及成本的影响。
这项基于横断面调查的研究纳入了80名患者，研究在荷兰一家大型地区医院的运动医学科进行。在进行任何干预之前收集数据。主要结局指标为欧洲五维度健康量表问卷（EQ-5D）。EQ-5D表示在自我护理、焦虑/抑郁、活动能力、日常活动和疼痛/不适等领域中存在中度/重度问题的百分比。次要结局指标为既往医疗就诊次数、症状发作期间的工作表现以及每位患者因AT导致的估计年度直接医疗成本和间接成本。
所有80名患者均完成了问卷调查。自我护理领域（1%）和焦虑/抑郁领域（20%）的EQ-5D评分较低，而活动能力领域（66%）、日常活动领域（50%）和疼痛/不适领域（89%）的评分较高。AT患者主要报告对工作效率有影响（38%）。因AT导致的旷工率为9%。年度医疗就诊总中位数（四分位间距）为9次（3 - 11次）。每位AT患者的估计年度总成本平均（标准差）为840欧元（1420欧元）（平均（标准差）为991美元（1675美元））。
本研究表明AT对生活质量和工作效率有重大影响。本研究还提供了有关AT社会经济影响的新信息，强调这种常见且长期存在的疾病会导致大量成本支出。这些发现强调了对AT进行优化治疗和改进预防干预措施的必要性。
NCT02996409
